Unfolded Protein Response: Silence without stress

  1. David J Young
  2. Nicholas R Guydosh  Is a corresponding author
  1. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, United States

Cells, much like humans, must deal with a variety of stresses during their daily lives and react appropriately. In the absence of stress, it is also important that cells do not waste valuable resources on unnecessary responses.

Many proteins are synthesized by ribosomes that are bound to the membrane that surrounds the endoplasmic reticulum. The new proteins are then transported into the endoplasmic reticulum and folded into their correct final forms by molecular chaperones. However, many factors can cause unfolded or misfolded proteins to accumulate within the endoplasmic reticulum, which stresses it. In budding yeast, cells respond to such stress by expressing a transcription factor called Hac1p. This transcription factor is then transported to the nucleus, where it directs the expression of additional chaperones and other factors that can alleviate the stress (Cox and Walter, 1996; Mori et al., 1996). Many parts of this pathway are conserved across eukaryotes.

To guarantee a speedy response to endoplasmic reticulum stress, the messenger RNA (mRNA) for HAC1 is stored in a ‘silenced’ form in the cytoplasm where it can be quickly activated (Chapman and Walter, 1997; Kawahara et al., 1997). Now, in eLife, Rachael Di Santo, Soufiane Aboulhouda and David Weinberg of the University of California, San Francisco, report the results of elegant experiments that reveal more details about the nature of this silencing mechanism (Di Santo et al., 2016). In addition, they reveal an intricate fail-safe mechanism that ensures the destruction of any Hac1 protein that escapes silencing.

Most mRNA molecules have regions called introns that are removed in a process called splicing before the mRNA molecules are translated into proteins. HAC1 mRNA contains an atypical intron region that, in the absence of endoplasmic reticulum stress, undergoes base-pairing interactions with its own 5’ untranslated region (5’UTR; Sidrauski et al., 1996; Sidrauski and Walter, 1997). During endoplasmic reticulum stress, a protein senses the accumulation of unfolded proteins in the endoplasmic reticulum and removes the HAC1 intron in response. This process leads to the expression of the full-length Hac1 protein (Figure 1).

A functional Hac1 protein is made only if a block that prevents the initiation of translation is removed.

(Left) The translation of two mRNA exons (shown here in blue and purple) results in the production of the Hac1 protein. However, unspliced HAC1 mRNA contains an intron (orange) that, in the absence of endoplasmic reticulum stress, undergoes base-pairing interactions with its own 5’UTR. These interactions prevent most 40S ribosomes (blue oval) from loading onto the mRNA and initiating translation. When the endoplasmic reticulum becomes stressed (middle panel), Ire1 proteins (black triangles) splice out the intron. The spliced HAC1 mRNA can then be translated to form the full-length Hac1 protein, which triggers the unfolded protein response in order to relieve endoplasmic reticulum stress. (Right) In the absence of stress, some 40S ribosomes (blue ovals) manage to bypass the base-pairing interactions. In this case, the second exon is not translated, and a new sequence is found at the C-terminal end of the protein (red). This "degron tag" is recognized by a protein adaptor called Duh1, which targets Hac1 for ubiquitination – a process that involves the formation of a complex that also includes E2, Cul1 and Skp1 proteins. This ubiquitination marks the protein for rapid degradation by the proteasome.

Two main models have emerged that attempt to explain how the HAC1 mRNA is silenced by the base-pairing interactions between the intron and the 5’UTR. In the first model, the ribosomes are blocked by the interactions and cannot start translating the mRNA. In the second model the interactions cause the ribosomes to "stall" shortly after translation begins (Rüegsegger et al., 2001).

The stalled ribosome model was suggested by results from experiments that used a sucrose gradient to separate out the mRNA molecules that were being translated (and hence were attached to ribosomes) from those that were not. The results of these experiments showed that the majority of HAC1 mRNAs were present in the polysome region of the sucrose gradient (where the majority of translation takes place). However, these results were called into question by ribosome-footprint profiling experiments by Weinberg and others that showed that ribosomes were nearly absent from HAC1 transcripts in exponentially growing yeast (Weinberg et al., 2016). Through careful experimentation, Di Santo et al. reveal that the association of HAC1 mRNA with polysomes in sucrose gradients was an artifact caused by non-specific interactions. Thus it appears that HAC1 is silenced because ribosomes cannot start the translation process.

Di Santo et al. then uncovered an additional silencing mechanism that targets the Hac1 protein for destruction. In sucrose gradient experiments, mutating either the 5’UTR or the intron sequences in order to disrupt the base-pairing interaction resulted in the distribution of the mutant mRNAs being shifted to the polysome fractions. Although this suggested that translation could be initiated on these mutant transcripts, no protein was detectable. Further investigation revealed that the Hac1 protein synthesized from this mRNA variant was unstable because the intron encoded a 10-amino-acid tail that acted as a destruction signal (or “degron” tag).

Degron-mediated loss of the Hac1 protein occurs rapidly, making it difficult to record experimentally (Cox and Walter, 1996; Chapman and Walter, 1997; Kawahara et al., 1997). Di Santo et al. overcame this challenge with a number of clever biochemical tricks and genomic screens. These identified a previously unknown protein adapter, Duh1p, which recognizes the degron tag on Hac1 and targets the protein for ubiquitination, marking it for subsequent degradation by the proteasome.

The combination of inhibited translation initiation and accelerated protein degradation, both of which are dependent on the HAC1 intron, provides exquisite control of Hac1 protein levels in the absence of endoplasmic reticulum stress. This finding raises the question of whether Duh1p may regulate other proteins and whether similar adaptors exist to regulate other degron tags in the cell. While the Hac1 protein was already known for the unusual way in which it is regulated, these discoveries add yet another plot twist to this fascinating story.

References

Article and author information

Author details

  1. David J Young

    Laboratory of Biochemistry and Genetics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Nicholas R Guydosh

    Laboratory of Biochemistry and Genetics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, United States
    For correspondence
    nicholas.guydosh@nih.gov
    Competing interests
    The authors declare that no competing interests exist.

Publication history

  1. Version of Record published:

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 1,316
    views
  • 151
    downloads
  • 0
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. David J Young
  2. Nicholas R Guydosh
(2016)
Unfolded Protein Response: Silence without stress
eLife 5:e22073.
https://doi.org/10.7554/eLife.22073
  1. Further reading

Further reading

    1. Chromosomes and Gene Expression
    2. Structural Biology and Molecular Biophysics
    Liza Dahal, Thomas GW Graham ... Xavier Darzacq
    Research Article

    Type II nuclear receptors (T2NRs) require heterodimerization with a common partner, the retinoid X receptor (RXR), to bind cognate DNA recognition sites in chromatin. Based on previous biochemical and overexpression studies, binding of T2NRs to chromatin is proposed to be regulated by competition for a limiting pool of the core RXR subunit. However, this mechanism has not yet been tested for endogenous proteins in live cells. Using single-molecule tracking (SMT) and proximity-assisted photoactivation (PAPA), we monitored interactions between endogenously tagged RXR and retinoic acid receptor (RAR) in live cells. Unexpectedly, we find that higher expression of RAR, but not RXR, increases heterodimerization and chromatin binding in U2OS cells. This surprising finding indicates the limiting factor is not RXR but likely its cadre of obligate dimer binding partners. SMT and PAPA thus provide a direct way to probe which components are functionally limiting within a complex TF interaction network providing new insights into mechanisms of gene regulation in vivo with implications for drug development targeting nuclear receptors.

    1. Cancer Biology
    2. Chromosomes and Gene Expression
    Ananda Kishore Mukherjee, Subhajit Dutta ... Shantanu Chowdhury
    Research Article

    Telomeres are crucial for cancer progression. Immune signalling in the tumour microenvironment has been shown to be very important in cancer prognosis. However, the mechanisms by which telomeres might affect tumour immune response remain poorly understood. Here, we observed that interleukin-1 signalling is telomere-length dependent in cancer cells. Mechanistically, non-telomeric TRF2 (telomeric repeat binding factor 2) binding at the IL-1-receptor type-1 (IL1R1) promoter was found to be affected by telomere length. Enhanced TRF2 binding at the IL1R1 promoter in cells with short telomeres directly recruited the histone-acetyl-transferase (HAT) p300, and consequent H3K27 acetylation activated IL1R1. This altered NF-kappa B signalling and affected downstream cytokines like IL6, IL8, and TNF. Further, IL1R1 expression was telomere-sensitive in triple-negative breast cancer (TNBC) clinical samples. Infiltration of tumour-associated macrophages (TAM) was also sensitive to the length of tumour cell telomeres and highly correlated with IL1R1 expression. The use of both IL1 Receptor antagonist (IL1RA) and IL1R1 targeting ligands could abrogate M2 macrophage infiltration in TNBC tumour organoids. In summary, using TNBC cancer tissue (>90 patients), tumour-derived organoids, cancer cells, and xenograft tumours with either long or short telomeres, we uncovered a heretofore undeciphered function of telomeres in modulating IL1 signalling and tumour immunity.